Psykolog Luise Bæk Bomme ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.7% 15.3% 17.8% 11.7% 16.4%  
Credit score (0-100)  8 12 8 19 11  
Credit rating  B BB B BB BB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  259 421 625 516 727  
EBITDA  -71.3 -28.5 46.4 -24.4 40.4  
EBIT  -71.3 -28.5 46.4 -24.4 40.4  
Pre-tax profit (PTP)  -73.4 -33.7 42.5 -25.2 40.4  
Net earnings  -57.3 -13.9 33.0 -20.1 31.2  
Pre-tax profit without non-rec. items  -73.4 -33.7 42.5 -25.2 40.4  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -114 -88.9 44.1 23.9 55.2  
Interest-bearing liabilities  153 141 1.5 1.5 1.5  
Balance sheet total (assets)  103 104 184 136 205  

Net Debt  81.3 85.8 -114 -2.1 -154  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  259 421 625 516 727  
Gross profit growth  487.8% 62.4% 48.3% -17.4% 41.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  103 104 184 136 205  
Balance sheet change%  1,518.8% 1.4% 75.8% -25.9% 50.9%  
Added value  -71.3 -28.5 46.4 -24.4 40.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 -1.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -27.5% -6.8% 7.4% -4.7% 5.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -50.9% -13.9% 24.6% -15.2% 23.7%  
ROI %  -70.0% -19.4% 49.7% -68.6% 98.5%  
ROE %  -104.9% -13.4% 44.4% -59.3% 79.0%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -52.6% -46.0% 24.0% 17.6% 26.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -114.0% -300.7% -245.0% 8.8% -379.9%  
Gearing %  -134.0% -158.9% 3.5% 6.4% 2.8%  
Net interest  0 0 0 0 0  
Financing costs %  2.1% 3.5% 5.5% 52.7% 0.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.4 0.5 1.3 1.0 1.2  
Current Ratio  0.4 0.5 1.3 1.0 1.2  
Cash and cash equivalent  71.5 55.4 115.3 3.7 155.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -122.6 -97.5 35.5 1.7 33.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -71 -29 46 -24 40  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -71 -29 46 -24 40  
EBIT / employee  -71 -29 46 -24 40  
Net earnings / employee  -57 -14 33 -20 31